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 Introduction 
 Access to quality affordable medicines is of public 
health importance and has remained a major challenge in 
developing countries, especially in Nigeria  [1] . A generic 
medicine is a ‘pharmaceutical product that is intended to 
be interchangeable with the innovator product, which is 
manufactured without a licence from the innovator com-
pany, and marketed after the expiration of the patent or 
other exclusivity rights’  [2] . Generic medicines are usu-
ally cheaper than innovator brands and therefore save 
costs on medicines  [3, 4] . In a cost-saving study conduct-
ed by Cameron et al.  [4] in 17 developing countries, they 
reported that ‘an average of 9–89% could be saved by an 
individual country in private sector purchases by switch-
ing from originator brands to lowest-priced generics’  [3] . 
 In Nigeria, payment for medicines is mainly out of pock-
et and no pricing formula exists for the sale of medicines 
 [5] . A national survey of 129 medicine outlets investigating 
the prices of 34 prescription medicines revealed that con-
sumers pay up to 64 times the international reference price 
of the medicines and the cost of innovator brands is be-
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 Abstract 
 Objective: To investigate the views of pharmacists in North-
Central Nigeria on generic medicines and generic substitu-
tion practices.  Subjects and Method: A cross-sectional sur-
vey was conducted in 4 cities in North-Central Nigeria from 
April to June 2012 among 330 pharmacists in hospital and 
community pharmacy settings, recruited through a conve-
nience sampling strategy. Data were collected using a pre-
validated self-administered questionnaire and entered into 
SPSS version 16.0 software to generate descriptive statistics. 
Binary logistic regression was conducted to determine the 
demographic predictors of preference for generic substitu-
tion among respondents.  Results: The response rate was 
46.7% (n = 154). Eighty-four (54.5%) respondents reported 
that generic medicines were not of equivalent quality to 
branded ones. There was no significant difference (p > 0.05) 
in the perception of respondents regarding the quality of 
imported generic medicines over locally manufactured 
ones. While 143 (92.9%) respondents supported generic 
substitution practices, 105 (68.2%) would prefer to recom-
mend generic medicines over branded ones. Hospital phar-
macists were more likely (OR = 2.6; 95% CI 1.2–5.8) than com-
munity pharmacists to recommend generic medicines. One 
hundred and fifty-three (99.4%) respondents would support 
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tween 2 and 7 times that of the lowest-priced generics  [6] . 
A recent national survey investigating access to medicines, 
conducted among 1,080 households, revealed that about 
30% of patients with chronic conditions do not take medi-
cines because they are unable to afford them  [1] .
 Even though legislation exists in Nigeria regarding ge-
neric prescribing, generic medicine prescribing is yet to 
be institutionalized. For example, an assessment of over 
4,000 medicine items included in 1,307 patients’ prescrip-
tions at the medical out-patient clinic of a tertiary hospi-
tal in Nigeria showed that only 49.5% of medicine items 
were prescribed as generics  [7] .
 Many studies have investigated pharmacists’ views 
and practices regarding generic medicines and have re-
ported positive benefits, including a reduction in treat-
ment costs and an increase in access to medicines  [8–10] . 
However, some concerns have been reported regarding 
generic medicines in terms of their quality and the likely 
impact of generic medicine substitution on patients’ ad-
herence to therapy  [9, 10] .
 The perception of health care professionals, including 
doctors and pharmacists, regarding generic medicine 
substitution has not been investigated in Nigeria. Given 
the role of pharmacists in the management of medicines, 
including the selection and dispensing of medicines, they 
could be an important point of intervention for promot-
ing generic medicine utilization in the health care system. 
This research was therefore carried out to investigate the 
views of pharmacists in North-Central Nigeria on gener-
ic medicines and generic substitution practices. 
 Subjects and Methods 
 Study Setting and Population 
 This study was conducted in 4 cities, i.e. Abuja, Keffi, Lafiya and 
Jos, located in North-Central Nigeria. These cities were chosen be-
cause they contain at least one tertiary hospital with a number of 
pharmacists employed as staff. In addition, there is a high presence 
of community pharmacies in these cities. The study population 
consisted of hospital and community pharmacists working in these 
cities. Inclusion criteria were that study participants had to be reg-
istered pharmacists and had to be working in either a community 
or hospital pharmacy. The hospitals used for this study consisted 
of government, mission (private and non-profit), and private (for-
profit) hospitals while the community pharmacies used were pri-
vately owned.
 Sample Size 
 The sample size of this study was calculated based on 95% CI, 
a margin of error of 5%, and the assumption that there are about 
1,000 pharmacists practicing in hospitals and community pharma-
cies in these cities. A sample size of 278 was obtained using an on-
line sample size calculator  [11] . However, 330 pharmacists were 
recruited for this study in order to accommodate for non-response 
among participants. 
 Questionnaire Development 
 The questionnaire used was developed based on a review of the 
literature investigating generic medicine utilization among phar-
macists  [3, 8, 9, 12] . The initial questionnaire developed was pilot 
tested on 20 academic pharmacists who had worked in a hospital 
or community pharmacy. They were asked for feedback regarding 
any grey areas on the questionnaire. The questionnaire was also 
evaluated for its ability to meet the study objectives and adjusted 
as required. The final version of the questionnaire contained 28 
items intended to measure respondents’ perception regarding ge-
neric medicines, generic substitution, and a future generic medi-
cine substitution policy in Nigeria. The questionnaire contained 
closed-ended questions, and respondents were given the opportu-
nity to comment freely at the end of the questionnaire on how ge-
neric medicine utilization can be improved in Nigeria.
 Study Design 
 A cross-sectional survey employing a self-administered ques-
tionnaire as the data collection tool was conducted from April to 
June 2012 among 330 pharmacists. The pharmacists were recruited 
through a convenience sampling strategy due to logistical challeng-
es and the non-availability of a sampling frame of hospital and com-
munity pharmacists to enable a probability sampling to be carried 
out. Several visits were made to hospitals and community pharma-
cies located in the 4 cities selected, and pharmacists who were pres-
ent at the time of the researchers’ visit and accepted the invitation 
to participate in the study were given the questionnaire. Follow-up 
visits for collection of the completed questionnaires were made 
within a month of the administration of the questionnaire. 
 Ethical Consideration 
 Approval for this study was granted by the Research Review 
Board of the Faculty of Pharmaceutical Sciences, University of Jos, 
Nigeria. Written informed consent was sought from each partici-
pant, participation in the study was voluntary, and the information 
obtained was anonymous and treated confidentially.
 Data Analysis 
 Data collected were entered into SPSS version 16.0 software 
(Chicago, Ill., USA) to generate descriptive statistics. Binary logis-
tic regression was conducted to determine the demographic pre-
dictors of a preference for generic substitution practices among 
respondents. No analysis was made against hospital pharmacists 
in the private sector as only 14 pharmacists from this sector par-
ticipated in this study because most private hospitals have no resi-
dent pharmacists. 
 Results 
 Of the 330 administered questionnaires, 154 (46.7%) 
were correctly filled out and returned, representing an 
overall response rate of 50.7% (113/223) and 38.3% 
(41/107) among hospital and community pharmacists, 
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respectively. Among the 113 hospital pharmacists, 99 
(87.6%) were from government hospitals, 9 (8.0%) were 
from private (for-profit) hospitals, and 5 (4.4%) were 
from mission (private and non-profit) hospitals. Demo-
graphic data of the 154 respondents of this study revealed 
that 100 (64.9%) were men and 54 (35.1%) were women; 
78 (50.6%) were between the ages of 30 and 39 years; 113 
(73.4%) were practicing as hospital pharmacists, and 115 
(74.7%) had no postgraduate degree ( table 1 ).
 Overall, 103 (66.9%) and 108 (70.1%) agreed that ge-
neric medicines were bioequivalent to and cheaper than 
branded medicines, respectively. Eighty-four (54.5%) re-
spondents reported that generic medicines were not of 
equivalent quality to branded ones. A Likert-type scale 
was used to evaluate respondents’ perception regarding 
the quality of imported and locally manufactured gener-
ics. Eighty-five (55.2%) respondents believed that im-
ported generics were of high quality, 63 (40.9%) believed 
they were of moderate quality, and 6 (3.9%) believed they 
were of low quality. Similarly, 79 (51.3%), 63 (40.9%), and 
12 (7.8%) respondents believed that locally manufactured 
generics were of high, moderate, and low quality, respec-
tively. Therefore, there was no significant difference (p > 
0.05) in the perception of respondents regarding the qual-
ity of imported generic medicines over locally manufac-
tured ones. 
 One hundred and forty-three (92.9%) respondents 
were in support of generic substitution; however, 112 
(72.7%) of them expressed concern that some situations 
exist in which generic substitution is not appropriate. Re-
spondents reported that patients usually have psycholog-
ical dissatisfaction (98; 63.6%), problems adhering to 
therapy (33; 21.4%), adverse/allergic reactions (27; 
17.5%), and poor clinical outcomes (27; 17.5%) when 
their regular branded medicines are substituted with ge-
neric ones. 
 This study also revealed that 105 (68.2%) respondents 
would prefer to recommend generic medicines over 
branded ones, while 49 (31.8%) respondents preferred to 
recommend branded medicines over generics in their 
practice. Respondents’ primary area of practice was the 
only identified demographic predictor of a preference for 
recommending generic medicines ( table  1 ). Hospital 
pharmacists were more likely (OR = 2.6) than commu-
nity pharmacists to recommend generic medicines ( ta-
ble 1 ). Cost-effectiveness (75.2%; 79/105) and customer 
satisfaction (31.4%; 33/105) were the common factors 
that influenced respondents’ preference for generics. 
Similarly, these factors, i.e. customer satisfaction (63.3%; 
31/49) and cost-effectiveness (34.7%; 17/49), commonly 
influenced those with a preference for branded medi-
cines, too. 
 Twenty-three (23, 14.9%) respondents reported that 
they regularly document and provide follow-up services 
to their patients when they switch their medicines from 
branded ones to generics. Common reasons given (n = 
131) for not documenting and following up generic sub-
stitution were the absence of regulations/guidelines to 
document or provide follow-up services (73; 55.7%), that 
the respondent did not think it was necessary (50; 38.2%), 
and that the clients were irregular (26; 19.8%).
 The reported impacts of generic medicines on the re-
spondents’ pharmacy practice were: much time was spent 
explaining the reasons for generic substitution to the cli-
ents (76; 49.4%), their relationship with the patient was 
affected when the generic medicine did not work (57; 
37.0%); it promoted drug availability (44; 28.6%); less 
funds were needed to stock generics (38; 24.7%), and it 
met their patients’ demand (37; 24.0%).
 When respondents’ views were sought concerning ex-
tending generic substitution rights to pharmacists in Ni-
geria, 153 (99.4%) respondents were in support of this 
policy direction. Sixty (39.0%) respondents reported that 
pharmacists should be allowed to perform generic substi-
tution without consulting the prescribing physician, 
Table 1.  Predictors of respondents’ preference for recommending 
generic medicines
Variable n Preference
for generics,
n (%)
OR
(95% CI)
p value
Gender
Male 100 68 (68.0) referent
Female 54 37 (68.5) 1.2 (0.5 – 2.8) 0.601
Age group
20 – 29 years 41 29 (70.7) referent
30 – 39 years 78 51 (65.4) 0.9 (0.3 – 2.8) 0.921
≥40 years 35 25 (71.4) 1.4 (0.3 – 6.4) 0.700
Primary area of practice
Hospital 113 84 (74.3) 2.6 (1.2 – 5.8) 0.018*
Community 41 21 (51.2) referent
Experience
0 – 5 years 67 48 (71.6) referent
6 – 10 years 46 30 (65.2) 0.9 (0.3 – 2.6) 0.826
≥11 years 41 27 (65.9) 0.7 (0.2 – 2.5) 0.536
Postgraduate degree
Yes 39 24 (61.5) referent
No 115 81 (70.4) 1.2 (0.5 – 2.9) 0.703
 n = 154. * p < 0.05.
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while 72 (46.8%) respondents reported that pharmacists 
only need to consult the prescribing physician when sub-
stituting certain groups of medicines. Eight (5.2%) re-
spondents were of the view that pharmacists must always 
consult the prescribing physician when performing ge-
neric substitution. The reasons given by respondents in 
support of granting pharmacists generic substitution 
rights were: to enhance the use of pharmacists’ skills (99; 
64.3%), to promote access to medicine (39; 25.3%), to re-
duce patients’ costs (13; 8.4%), to promote the rational 
use of medicines (11; 7.1%), to promote pharmacists’ job 
satisfaction (7; 4.5%), and that getting back to the physi-
cian takes time (4; 2.6%). 
 Respondents’ comments on how to improve the use of 
generic medicines in the country were centred on regula-
tion and policy, education of health professionals, local 
manufacturing of generic medicines, granting pharma-
cists prescribing rights and collaborative practice be-
tween physicians and pharmacists ( table 2 ).
 Discussion 
 The high support (92.9%) for generic substitution in 
this study is comparable to those found in New Zealand 
and Malaysia, where 89.4%  [9] and 84.7%  [13] supported 
generic medicine substitution. Although the respondents 
in this study demonstrated a high support for generic 
substitution, the majority of them (72.7%) were of the 
opinion that generic substitution is not appropriate in all 
situations, similar to other studies  [13, 14] . In these stud-
ies, generic medicine substitution was not considered ap-
propriate for medicines with a narrow therapeutic index, 
including those affecting the nervous system and those 
prescribed for obstructive airway diseases  [13, 14] . Du-
erden and Hughes  [15] , in their review, outlined a num-
ber of situations in which generic medicine substitution 
may be considered inappropriate, including instances 
where pharmacokinetic differences may be evident, 
where there is a significant danger of medication error, 
and where modified release medicines are not inter-
changeable. 
 The present study also confirmed findings from other 
studies in which pharmacists reported that generic medi-
cines were not of equivalent quality to branded ones  [9, 
12] . This finding has implications on the level of confi-
dence pharmacists have in generics, and the generic med-
icine approval/regulatory system. Since pharmacists’ per-
ception of generic medicines can influence generic sub-
stitution, the revealed poor perception of generic 
medicines can be corrected by building pharmacists’ con-
fidence in the generic medicine approval system. In the 
case of Nigeria, building confidence in the activities of the 
National Agency for Food, Drug Administration and 
Control, the agency responsible for registering medicines 
in Nigeria (based on a demonstrated bioequivalence and 
good manufacturing practices), would enhance generic 
medicine utilization  [16] .
 A low percentage (21.4%) of the respondents in this 
study reported difficulty adhering to therapy as one of the 
challenges patients encountered when their regular med-
icines were substituted; however, this finding is still de-
batable. A Norwegian study reported that one third of the 
patients found it difficult to keep track of their medica-
tions when their regular branded medicines were substi-
tuted, and this presented a challenge to them in adhering 
Table 2.  Major themes on how to improve generic medicine utilization in Nigeria
Theme Supporting quote
Regulation and policy ‘generic medicine policy should be institutionalized in Nigeria to encourage the selection and 
use of generic medicines’ (R23)
‘quality control/quality assurance should be enforced so that generics will be of the same stan-
dard like their branded counterparts’ (R103)
Education of health professionals ‘doctors should be adequately educated on the need to prescribe using generic names’ (R35)
Local manufacturing ‘empower local manufacturing of generic medicines by reputable companies’ (R62)
Granting pharmacists prescribing 
rights
‘pharmacist should be given the right of prescribing as it is practised in advanced countries’ 
(R55)
Collaborative practise between 
physicians and pharmacists
‘doctors and pharmacists should work together in prescribing and dispensing drugs base on 
their generic names and not brand names’ (R98)
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to therapy  [17] . However, a cohort study in the Nether-
lands demonstrated that generic substitution does not af-
fect adherence  [18] . 
 In North-Central Nigeria, hospital pharmacies are 
usually stocked based on the medicines on the essential 
drug list which contains names of medicines in generic. 
Most hospitals, therefore, stock their pharmacies with ge-
neric medicines and dispensing is usually based on the 
generic medicines available. This practice has probably 
influenced the hospital pharmacists’ preference for ge-
nerics, as seen in this study. On the other hand, commu-
nity pharmacies are profit driven, and their clients usu-
ally present to them with requests for a specific brand-
name medicine. This also may account for why 
respondents who prefer to recommend branded medi-
cines in this study commonly reported customer satisfac-
tion as a major reason for their preference. Generally, 
these factors are likely to have influenced community 
pharmacists’ preference for branded medicines. Hence, 
there is a need for targeted interventions to promote the 
use of generic medicines among community pharmacists.
 The present study shows that documentation and fol-
low-up of generic substitution among pharmacists in 
North-Central Nigeria is poor. Documentation is a core 
tenet of pharmaceutical care  [19] . Hence, regular docu-
mentation and follow-up of patients, especially those in 
chronic care whose regular medicines have been substi-
tuted, should be promoted among pharmacists. This will 
enable pharmacists to keep track of patient therapy and 
monitor treatment outcomes and any adverse event fol-
lowing generic substitution.
 Generic medicines have had positive and negative im-
pacts on pharmacy practice, including the promotion of 
medicine availability, less money needed to stock phar-
macies with generics, more time spent explaining the rea-
sons for the substitution to customers, and that the phar-
macist’s relationship with the patient may be affected 
when the generic medicine does not work. These effects 
are more likely to be felt in community pharmacy prac-
tices. More than two thirds of the 287 community phar-
macists who participated in a survey in New Zealand re-
ported that generic medicines affect the profitability of 
their pharmacies because more time is spent explaining 
the medication changes to the patients and sales volumes 
had to be increased to maintain a profit  [9] . 
 There was a high support (99%) for future generic sub-
stitution rights for pharmacists in Nigeria. The over-
whelming support obtained in this study is similar to that 
found in separate studies involving community pharma-
cists in France and Malaysia in which 90 and 93.6% of 
respondents, respectively, were in support of generic sub-
stitution rights for pharmacists in their respective coun-
try of practice  [3, 20] . This new policy direction has im-
plications for generic medicine utilization in Nigeria, as 
it will empower pharmacists where appropriate to substi-
tute branded medicines with generically equivalent ones. 
 The convenience sampling design and the low re-
sponse rate constitute a hindrance for the generalization 
of the findings of this study. In addition, this study was 
carried out in urban settings; hence, the views of pharma-
cists in rural settings were not captured, and they could 
be different from those obtained in this research. 
 Some issues have emerged from this study, including 
the confidence of pharmacists in the quality of generic 
medicines, factors influencing pharmacists’ preference for 
generic medicines, conditions in which generic substitu-
tion is considered inappropriate, regulation and policy 
change. It will be important to further explore these con-
cerns in a qualitative study in order to have a comprehen-
sive understanding of the perspectives of the respondents.
 Conclusions 
 The present study showed a high support for generic 
substitution in North-Central Nigeria and the implemen-
tation of future generic substitution rights for Nigerian 
pharmacists. Many respondents lacked confidence in the 
quality of the generics available on the Nigerian market. 
However, the convenience sampling design and the low 
response rate in this study affect the generalizability of 
this research.
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